home / stock / oncy / oncy news


ONCY News and Press, Oncolytics Biotech Inc. From 08/25/20

Stock Information

Company Name: Oncolytics Biotech Inc.
Stock Symbol: ONCY
Market: NASDAQ
Website: oncolyticsbiotech.com

Menu

ONCY ONCY Quote ONCY Short ONCY News ONCY Articles ONCY Message Board
Get ONCY Alerts

News, Short Squeeze, Breakout and More Instantly...

ONCY - Billions Pouring Into Drugs That Could Treat Cancer Patients with High TROP2 Expressions

In the fight against some of the most challenging forms of cancer, AstraZeneca PLC (NYSE:AZN) recently placed a giant $6 billion bet on an antibody-drug conjugate (ADC) called DS-1062 from Japanese developers Daiichi Sankyo. The move signalled AZ's confidence that this solid tumor drug coul...

ONCY - Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 40th Annual Growth Conference

Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 40th Annual Growth Conference Fireside chat to take place on Wednesday, August 12 at 8:00 am ET Canada NewsWire SAN DIEGO, Calif. and CALGARY, AB, Aug. 10, 2020 SAN DIEGO, Calif. an...

ONCY - Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2020 Results - Earnings Call Transcript

Oncolytics Biotech Inc. (ONCY) Q2 2020 Earnings Conference Call August 04, 2020 04:30 PM ET Company Participants Tom Galassi - Investor Relations Matt Coffey - President & Chief Executive Officer Andrew de Guttadauro - Global Head of Business Development Kirk Look –...

ONCY - Oncolytics Biotech EPS misses by $0.06

Oncolytics Biotech (NASDAQ: ONCY ) : Q2 GAAP EPS of -$0.17 misses by $0.06 . $29.9M in cash and cash equivalents. Shares  -1.8% Press Release More news on: Oncolytics Biotech Inc., Earnings news and commentary, Healthcare stocks news, ,

ONCY - Oncolytics Biotech® Reports 2020 Second Quarter Financial Results and Operational Highlights

SAN DIEGO and CALGARY, Alberta , Aug. 4, 2020 /PRNewswire/ -- Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and operational highlights for the quarter ended June 30, 2020 . All dollar amounts are expressed in Canadian currency unle...

ONCY - Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights Conference call and webcast to take place on Tuesday, August 4, 2020 at 4:30 pm ET Canada NewsWire SAN DIEGO and CALGARY, AB, July 29, 2020 SAN DIEGO a...

ONCY - CORRECTION-New Research for Immunotherapy Combinations with Paclitaxel Helping in Breast Cancer Fight

July 23, 2020 FN Media Group Presents USA News Group News Commentary (Correction: An earlier version of this article contained an error, incorrectly called the Athenex’s oral paclitaxel ‘Abraxane’. Abraxane is not owned by Athenex, but is actually owned ...

ONCY - New Research for Immunotherapy Combinations with Paclitaxel Helping in Breast Cancer Fight

Researchers at the University of Cincinnati Cancer Center have found a potential new combination therapy for breast cancer that would integrate the body’s immune system with targeted treatment for a protein that advances cancer. The UC study came on the heels of other announcements ...

ONCY - New Drug Developments and Combinations Aiding Badly Neglected Triple-Negative Breast Cancer Patients

July 15, 2020 FN Media Group Presents USA News Group News Commentary Vancouver, BC – July 15, 2020 – USA News Group   – A recent study from the National Comprehensive Cancer Center (NCCN) delivered a shocking indictment of the oncology field as a...

ONCY - Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles

June 25, 2020 FN Media Group Presents USA News Group News Commentary Los Angeles, CA – June 25, 2020 – USA News Group  – In a major step forward, engineers from MIT have designed nanoparticles that stimulate the immune system, helping it to attack tumo...

Previous 10 Next 10